Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

62.13
+0.63111.03%
Volume:297.28K
Turnover:18.35M
Market Cap:5.82B
PE:26.46
High:62.30
Open:60.80
Low:60.14
Close:61.50
52wk High:73.78
52wk Low:48.26
Shares:93.67M
Float Shares:58.75M
Volume Ratio:0.38
T/O Rate:0.51%
Dividend:1.44
Dividend Rate:2.32%
EPS(TTM):2.35
EPS(LYR):2.62
ROE:8.76%
ROA:5.15%
PB:2.25
PE(LYR):23.71

Loading ...

Dolby Laboratories Is Maintained at Outperform by Barrington Research

Dow Jones
·
Jun 15

Dolby Laboratories Is Maintained at Buy by Rosenblatt

Dow Jones
·
Jun 11

Analysts Offer Insights on Industrial Goods Companies: CryoPort (CYRX) and Dolby Laboratories (DLB)

TIPRANKS
·
Jun 11

Press Release: CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies

Dow Jones
·
Jun 10

Dolby partners with Deutsche Telekom’s MagentaTV for FIFA World Cup 2026 broadcasts in Germany

Reuters
·
Jun 10

Dolby, NBCUniversal partner to stream Telemundo’s 2026 FIFA World Cup coverage on Peacock in Dolby Vision, Atmos

Reuters
·
Jun 05

Cognition Therapeutics Advances Zervimesine Toward Phase 3 DLB Trial

TIPRANKS
·
Jun 04

Dolby SVP Entertainment John Couling sells 7,666 shares for $426,115.12

Reuters
·
Jun 04

Wall Street Analysts Are Bullish on Top Industrial Goods Picks

TIPRANKS
·
Jun 04

A Look At Dolby Laboratories (DLB) Valuation After Weak Guidance Offsets Revenue Beat

Simply Wall St.
·
Jun 02

Cognition Therapeutics Participating in Upcoming Investor Conferences

GlobeNewswire
·
Jun 01

Dolby expands rednote collaboration with Dolby Atmos video support

Reuters
·
May 29

Analysts Offer Insights on Industrial Goods Companies: Dolby Laboratories (DLB) and Electro Optic Systems Holdings Limited (OtherEOPSF)

TIPRANKS
·
May 27

A Look At Dolby Laboratories (DLB) Valuation After Recent Share Price Pullback

Simply Wall St.
·
May 21

Cognition Therapeutics Advances Zervimesine Toward Late-Stage DLB Trial

TIPRANKS
·
May 21

Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis

GlobeNewswire
·
May 21

Dolby SVP Shriram Revankar disposes 7,329 shares worth $401,901.09

Reuters
·
May 20

Dolby CEO Yeaman presents at William Blair Growth Stock Conference

Reuters
·
May 20

Boris Peaker Reiterates Buy on Neflamapimod Developer, Backs $20 Price Target on Pivotal DLB Phase III and Broad 2026 Clinical Catalysts

TIPRANKS
·
May 19

Press Release: Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Dow Jones
·
May 14